Loading stock data...

Lotus Eye Hospital and Institute Limited

NSE: LOTUSEYE

NSE
123.00 4.51 (3.81%)

Prev Close

118.49

Open Price

121

Volume

48,141

Today Low / High

118.6 / 123.5

52 WK Low / High

54.99 / 139.2

Range

117 - 129

Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 123, with a change of 4.51 (3.80623%). The expected target range on the NSE is between 117 - 129. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.

01 Oct 121.00 1.56%
30 Sep 115.00 3.03%
29 Sep 118.15 -0.70%
26 Sep 119.12 -0.78%
25 Sep 121.00 -1.55%
24 Sep 123.35 -2.36%
23 Sep 125.00 -3.26%
22 Sep 119.57 2.57%
19 Sep 118.50 1.92%
18 Sep 123.56 -2.48%
17 Sep 125.75 -1.74%
16 Sep 126.80 -3.49%
15 Sep 120.00 3.52%
12 Sep 119.69 0.94%
11 Sep 121.00 -0.08%
10 Sep 129.70 -6.41%
09 Sep 122.50 3.38%
08 Sep 117.50 8.23%
05 Sep 129.00 -5.75%
04 Sep 129.50 -2.56%

Lotus Eye Hospital and Institute Limited Graph

Lotus Eye Hospital and Institute Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Lotus Eye Hospital and Institute Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 123.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 123.00 124.23 111.81 - 136.65
125.46 100.37 - 150.55
126.69 88.68 - 164.70
Bearish Scenario 123.00 121.77 109.59 - 133.95
120.54 96.43 - 144.65
119.31 83.52 - 155.10

Overview of Lotus Eye Hospital and Institute Limited

ISIN

INE947I01017

Industry

Medical - Care Facilities

Vol.Avg

125,904

Market Cap

2,557,948,590

Last Dividend

0

Official Website

Visit Website

IPO Date

2008-07-11

DCF Diff

104.27

DCF

19

Financial Ratios Every Investor Needs

Stock Dividend of LOTUSEYE

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2023-09-18 September 18, 23 0.5 0.5 2023-09-18 2023-10-25
2022-09-08 September 08, 22 0.5 0.5 2022-09-10 2022-10-22
2021-09-08 September 08, 21 0.5 0.5 2021-09-10 2021-10-17
2018-09-14 September 14, 18 0.5 0.5 2018-09-17 2018-10-24 2018-05-29
2017-08-02 August 02, 17 0.5 0.5 2017-08-03 2017-09-09 2017-05-27

Stock Rating Details for LOTUSEYE

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 49.56 Cr 39.52 Cr 10.04 Cr 0.2026 0.00 Cr 0.00 Cr 0.43 Cr 0.74 Cr 0.34 4.74 Cr 0.0149
2024-03-31 48.21 Cr 34.64 Cr 13.57 Cr 0.2814 0.05 Cr 2.18 Cr 10.05 Cr 2.91 Cr 1.40 7.94 Cr 0.0605
2023-03-31 47.04 Cr 22.73 Cr 24.32 Cr 0.5169 0.00 Cr 2.05 Cr 4.71 Cr 4.08 Cr 1.96 8.84 Cr 0.0867
2022-03-31 38.09 Cr 18.83 Cr 19.25 Cr 0.5055 0.00 Cr 0.57 Cr 3.47 Cr 2.98 Cr 1.44 6.81 Cr 0.0784
2021-03-31 31.67 Cr 15.65 Cr 16.01 Cr 0.5057 0.00 Cr 0.52 Cr 1.32 Cr 1.57 Cr 0.75 4.46 Cr 0.0495

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 4.15 Cr 69.57 Cr 9.57 Cr 60.0003 Cr 3.43 Cr -0.72 Cr 3.83 Cr 53.94 Cr 0.00 Cr 0.00 Cr 2.39 Cr 7.4246 Cr
2024-03-31 2.65 Cr 66.63 Cr 7.22 Cr 59.4092 Cr 1.11 Cr -1.54 Cr 3.21 Cr 48.65 Cr 0.00 Cr 0.00 Cr 0.00 Cr 6.2268 Cr
2023-03-31 3.60 Cr 63.19 Cr 5.61 Cr 57.5794 Cr 0.67 Cr -2.93 Cr 2.79 Cr 44.07 Cr 0.33 Cr 0.00 Cr 0.95 Cr 5.1916 Cr
2022-03-31 3.79 Cr 61.60 Cr 6.99 Cr 54.6086 Cr 1.24 Cr -2.55 Cr 2.31 Cr 43.95 Cr 0.00 Cr 0.00 Cr 0.00 Cr 5.7566 Cr
2021-03-31 5.18 Cr 59.23 Cr 6.53 Cr 52.6967 Cr 0.40 Cr -4.78 Cr 1.78 Cr 40.37 Cr 0.00 Cr 0.16 Cr 0.00 Cr 5.8176 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 2.7022 Cr -4.3502 Cr -1.2416 Cr -2.1250 Cr 1.3873 Cr 4.1508 Cr -4.8272 Cr 0.7393 Cr 0.0000 Cr -0.0107 Cr -0.6180 Cr
2024-03-31 5.6834 Cr -4.6327 Cr -3.4018 Cr 0.0403 Cr -2.3511 Cr 6.9295 Cr -5.6431 Cr 2.9145 Cr -2.2646 Cr -1.0398 Cr -0.4210 Cr
2023-03-31 4.3871 Cr -2.1944 Cr -1.7051 Cr 1.2901 Cr 0.4876 Cr 9.2806 Cr -3.0970 Cr 5.6539 Cr -0.5677 Cr -1.0398 Cr -0.4853 Cr
2022-03-31 4.4115 Cr -3.9355 Cr -1.5754 Cr -0.2734 Cr -1.0994 Cr 8.7930 Cr -4.6849 Cr 4.1035 Cr -0.4137 Cr -1.0336 Cr -0.5258 Cr
2021-03-31 2.7305 Cr 0.4855 Cr -0.3191 Cr 2.2548 Cr 2.8969 Cr 9.8924 Cr -0.4757 Cr 1.9111 Cr -0.2628 Cr 0.0000 Cr 0.3333 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 13.52 Cr 6.80 Cr 6.72 Cr 0.4970 0.66 Cr 0.54 Cr 0.26 1.67 Cr 0.0403
2025-03-31 11.51 Cr 8.47 Cr 3.04 Cr 0.2644 0.42 Cr 0.25 Cr 0.12 0.35 Cr 0.0219
2024-12-31 12.25 Cr 6.17 Cr 6.08 Cr 0.4962 -0.52 Cr -0.24 Cr -0.11 1.01 Cr -0.0195
2024-09-30 12.91 Cr 6.45 Cr 6.46 Cr 0.5004 -0.08 Cr 0.10 Cr 0.05 1.41 Cr 0.0080
2024-06-30 12.89 Cr 9.97 Cr 2.92 Cr 0.2268 0.61 Cr 0.62 Cr 0.30 1.97 Cr 0.0484

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 4.15 Cr 0.00 Cr 4.15 Cr 1.32 Cr 3.83 Cr 11.57 Cr 53.94 Cr 69.57 Cr 9.57 Cr
2024-12-31 0.00 Cr 0.00 Cr 4.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -60.11 Cr
2024-09-30 0.31 Cr 4.24 Cr 4.54 Cr 1.56 Cr 3.89 Cr 11.78 Cr 52.77 Cr 70.07 Cr 9.97 Cr
2024-06-30 0.00 Cr 0.00 Cr 6.93 Cr 0.00 Cr 0.00 Cr 6.93 Cr 0.00 Cr 0.00 Cr -59.41 Cr
2024-03-31 2.65 Cr 4.28 Cr 6.93 Cr 1.26 Cr 3.21 Cr 14.02 Cr 48.65 Cr 66.63 Cr 7.22 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 -0.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 0.66 Cr 1.96 Cr 0.00 Cr 0.00 Cr 1.96 Cr 11.42 Cr 9.45 Cr 0.00 Cr 1.96 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Care Facilities

Company Name Symbol Price Market Cap Volume
Max Healthcare Institute Limited MAXHEALTH ₹1,111.90 ₹1,080,985,716,432.00 ₹3,265,883.00
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹7,460.00 ₹1,072,635,070,520.00 ₹220,764.00
Fortis Healthcare Limited FORTIS ₹989.00 ₹746,653,608,372.00 ₹2,567,244.00
Narayana Hrudayalaya Limited NH ₹1,733.00 ₹352,081,882,789.00 ₹271,104.00
Global Health Limited MEDANTA ₹1,309.00 ₹351,740,184,411.00 ₹152,741.00
Aster DM Healthcare Limited ASTERDM ₹631.70 ₹326,473,589,482.00 ₹294,027.00
Krishna Institute of Medical Sciences Limited KIMS ₹689.90 ₹276,055,851,257.00 ₹396,572.00
Rainbow Children's Medicare Limited RAINBOW ₹1,342.30 ₹136,312,825,433.00 ₹292,600.00
Jupiter Life Line Hospitals Limited JLHL ₹1,508.00 ₹98,873,561,176.00 ₹34,998.00
HealthCare Global Enterprises Limited HCG ₹645.80 ₹90,044,091,615.00 ₹260,090.00
Yatharth Hospital & Trauma Care Services Limited YATHARTH ₹750.00 ₹72,265,767,750.00 ₹217,670.00
Indraprastha Medical Corporation Limited INDRAMEDCO ₹455.00 ₹41,711,215,000.00 ₹121,862.00
Kovai Medical Center and Hospital Limited KOVAI ₹2,581.00 ₹35,290,787,300.00 ₹5,780.00
Artemis Medicare Services Limited ARTEMISMED ₹235.86 ₹32,768,007,393.00 ₹59,502.00
Shalby Limited SHALBY ₹263.65 ₹28,280,879,956.00 ₹799,138.00

Key Executives

Chief Executive Officer & Executive Director
Dr. Kuttapalayam Songappan Ramalingam M.D.

Gender: Not Specified

Year Born: 1950

Vice President of Administration
Dr. Rajkumar Sundaramoorthy

Gender: Not Specified

Year Born:

MD & Director
Ms. Sangeetha Sundaramoorthy

Gender: female

Year Born: 1978

Chief Financial Officer
Mr. Ramanujam Reghunathan

Gender: male

Year Born: 1957

Company Secretary & Compliance Officer
Mr. Mohanmenon Achuth Menon

Gender: male

Year Born:

FAQs about Lotus Eye Hospital and Institute Limited

Who is the CEO of the company?

The CEO is Kuttapalayam Songappan Ramalingam.

What is the current market price of the stock?

The current price is ₹123.00.

What is the 52-week price range?

The range is ₹54.99-139.2.

What is the market capitalization of the company?

The market capitalization is ₹255.79 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 390.09.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Lotus Eye Hospital and Institute Limited (ISIN: INE947I01017) is a leading Medical - Care Facilities in India. With a market capitalization of ₹255.79 crores and an average daily volume of 125,904 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.